Inclacumab (Anti-P-Selectin / CD62p)
Inclacumab (Anti-P-Selectin / CD62p) is a humanized monoclonal IgG4 antibody selectively targets P-selectin. It reduces cell adhesion showing potential for prevention of sickle cell disease (SCD). MW :150 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2616 |
| Sku # | A2616-1mg*5 |
| Pricing | 1mg*5, $1690.00 |